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Genetic screens for modifiers of activated Ras phenotypes have identified a novel protein, kinase suppressor
of Ras (KSR), which shares significant sequence homology with Raf family protein kinases. Studies using
Drosophila melanogaster and Caenorhabditis elegans predict that KSR positively regulates Ras signaling; how-
ever, the function of mammalian KSR is not well understood. We show here that two predicted kinase-dead
mutants of KSR retain the ability to complement ksr-1 loss-of-function alleles in C. elegans, suggesting that
KSR may have physiological, kinase-independent functions. Furthermore, we observe that murine KSR forms
a multimolecular signaling complex in human embryonic kidney 293T cells composed of HSP90, HSP70,
HSP68, p50CDC37, MEK1, MEK2, 14-3-3, and several other, unidentified proteins. Treatment of cells with
geldanamycin, an inhibitor of HSP90, decreases the half-life of KSR, suggesting that HSPs may serve to
stabilize KSR. Both nematode and mammalian KSRs are capable of binding to MEKs, and three-point
mutants of KSR, corresponding to C. elegans loss-of-function alleles, are specifically compromised in MEK
binding. KSR did not alter MEK activity or activation. However, KSR-MEK binding shifts the apparent
molecular mass of MEK from 44 to >700 kDa, and this results in the appearance of MEK in membrane-
associated fractions. Together, these results suggest that KSR may act as a scaffolding protein for the Ras-
mitogen-activated protein kinase pathway.
Ras activation is an essential step in signaling in response to
a variety of extracellular signals, including receptor tyrosine
kinase ligands which bind and activate their corresponding
tyrosine kinase receptors. Activation of receptor tyrosine ki-
nases leads to activation of Ras via the action of specific gua-
nine nucleotide exchange factors. Activated Ras can physically
interact with numerous downstream targets and activate sev-
eral different signaling pathways (15).
One of the best-characterized Ras signaling pathways is the
Raf-MEK-ERK pathway, also known as the mitogen-activated
protein (MAP) kinase cascade (20, 25). Ras directly binds Raf
in a GTP-dependent manner, and this interaction appears to
be critical for recruitment of Raf to the membrane, where it
undergoes activation. Activated Raf directly phosphorylates
and activates MEK, also known as MAP kinase kinase, which
in turn directly phosphorylates and activates ERK (25). Acti-
vation of ERK is critical for numerous Ras-induced cellular
responses, including transcriptional activation of a number of
genes (11). Ternary complex factors (TCFs) are among the
best-characterized physiological substrates of ERK. Activated
ERK directly phosphorylates and thereby activates the tran-
scription activation potential of TCFs (8, 12, 18). It appears
that TCFs, in association with the serum response factor, play
an essential role in the activation of many mitogen-inducible
genes (11).
The Ras-MAP kinase pathway is highly conserved in eu-
karyotes. Genetic studies of Caenorhabditis elegans and Dro-
sophila melanogaster indicate that this pathway is involved in
many developmental programs (15). Genetic screens for mu-
tations that suppress constitutively active Ras mutants have
identified numerous components of the MAP kinase pathway.
Such screens identified KSR (for kinase suppressor of Ras), a
putative protein kinase with significant sequence identity to
Raf (17, 30, 31). Genetic data indicated that KSR plays a
positive role in Ras signaling and functions parallel to, or
downstream of, Ras. Microinjection experiments using Xeno-
pus oocytes showed that KSR is able to enhance Ras-induced
germinal vesicle breakdown and MAP kinase activation, indi-
cating that KSR has a positive role in Ras signaling in verte-
brates (32). However, recent reports suggest that KSR may
have a negative role in certain aspects of Ras signaling (6, 14,
29, 39). KSR was found to inhibit Ras-induced cellular trans-
formation in NIH 3T3 cells and to inhibit MEK and/or ERK
activation (6, 14, 39). However, the mechanism of this inhibi-
tion remains to be elucidated. We have previously reported
that KSR selectively inhibits TCF phosphorylation and tran-
scription activity, without significantly affecting ERK activation
in COS1 cells (29). Therefore, the biochemical function of
KSR in mammalian cells is rather perplexing, though KSR
clearly plays a role in Ras-MAP kinase signal transduction.
The deduced amino acid sequence of KSR predicts it to be
a protein kinase, and one report has suggested that KSR is
a ceramide-activated protein kinase (40). However, whether
KSR has intrinsic kinase activity remains to be confirmed. It
has been proposed that KSR may function as a scaffold protein
to assemble a signaling complex in mammalian cells (14, 39).
Some limited data exist to support this notion. Previous studies
have suggested that KSR can interact directly with 14-3-3 pro-
teins, MEK, and possibly ERK (6, 14, 37, 39). In addition, KSR
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translocates to membrane fractions and associates with Raf
(perhaps indirectly) in a Ras-dependent manner (22, 37).
We tested the hypothesis that KSR may function indepen-
dently of its presumed protein kinase activity. Surprisingly, we
observed that upon microinjection, kinase domain mutants of
KSR complement KSR loss-of-function alleles in C. elegans
vulval induction. With this in mind, we turned our attention to
the mouse homolog of KSR (mKSR), testing whether kinase-
independent functions of mKSR exist in mammalian cells and
whether they are sensitive to mutations analogous to geneti-
cally isolated loss-of-function alleles. Consistent with this pos-
sibility, we observed that KSR is a component of a multi-
molecular complex in human embryonic kidney (HEK) 293T
cells consisting of MEK1, MEK2, HSP90, HSP70, HSP68,
p50CDC37, and 14-3-3 in addition to several other, unidentified
proteins. ERK also associates with KSR, though this binding
appears to be much weaker than KSR-MEK interactions. A
loss-of-function mutant, KSR C809Y, specifically lacks the
ability to interact with MEK yet retains the ability to bind other
KSR-associated proteins. Interestingly, ectopic KSR expres-
sion alters the apparent molecular mass of MEK from 44 kDa
to approximately 700 kDa and results in the translocation of
MEK from a soluble to a membrane-associated fraction.
Treatment of PC12 cells with nerve growth factor (NGF) re-
sulted in induction of KSR protein levels and a concomitant
increase in KSR-MEK association, suggesting that KSR may
play a role in vertebrate differentiation. These data suggest
that KSR may function as a scaffolding protein in vivo.
MATERIALS AND METHODS
C. elegans strains and plasmids. Standard methods were used for the handling
and culture of animals (2). Mutations used were let-60(n1046) (G13E) (1, 9),
ksr-1(ku68) (R531H) (29), and ksr-1(n2526) (W255STOP) (17). The ksr-1 trans-
genes pMS44 (wild type), pMS77 (K503M), pMS108 (D618A), and pMS153
(R531H) consist of genomic positions 1809 (BamHI) to 15401 (BamHI) from
cosmid F13B9 (GenBank accession no. U39853), followed by cDNA positions
520 (BamHI) to 2394 (ClaI) from ksr-1 (GenBank accession no. U38820), fol-
lowed by genomic positions 19965 (ClaI) to 21454 (SacII) from cosmid F13B9, in
pBluescript SK(1). Point mutations were introduced into the cDNA fragment by
PCR. For in vitro translation, C. elegans KSR-1 cDNAs were cloned into the
BamHI site pcDNA3-HA (29) to create either pMS82 or pMS83. C. elegans
KSR-1b (CeKSR-1b; pMS183) consists of the entire cDNA; CeKSR-1a
(pMS182) begins from an alternate initiation methionine at position 189 and may
be a naturally occurring variant (29a).
Cell culture. HEK 293T cells were cultured in Dulbecco’s modified Eagle’s
medium (DMEM) containing 10% fetal bovine serum (FBS; Life Technologies).
Transfections were performed by using Lipofectamine (Life Technologies) as
directed by the manufacturer. Rat PC12 cells were cultured in DMEM contain-
ing 10% horse serum and 5% FBS and were induced to differentiate by incu-
bating in DMEM containing 2% horse serum, 1% FBS, and 50 ng of NGF
(Calbiochem) per ml for 5 days, with a change of medium every 48 h.
Plasmids and protein expression. To construct a yeast expression vector for
two-hybrid screening, the entire open reading frame of mKSR was subcloned
into the bait vector plex-Ade (kindly provided by Anne Vojtek), creating an
in-frame fusion with LexA. To construct Lex-Ade-KSR KD and Lex-Ade-KSR
KD C809Y fusions, a 1,188-bp EcoRV fragment from pcDNA3-HA-KSR or
pcDNA3-HA-KSR C809Y (see below) was ligated into plex-Ade that had been
digested with BamHI and blunted with Klenow polymerase. MEK1-Gal4 activa-
tion domain fusions were constructed by ligating the entire open reading frame
of human MEK1 or MEK1Dproline rich (kindly provided by Melanie Cobb) into
pGAD10 (Clontech). Expression vectors encoding point mutants of murine KSR
were constructed by site-directed mutagenesis of pcDNA3-HA-KSR (29), using
a Quick Change kit (Stratagene). pcDNA3-HA-KSR 1-301 was constructed by
amplifying amino acids 1 to 301 of mKSR via PCR and subcloning into the
XbaI-EcoRI sites of pcDNA3-HA (29). HA-KSR KD was constructed by ampli-
fying the region coding for amino acids 500 to the stop codon of mKSR and
subcloning as an XbaI-EcoRI fragment into pcDNA3-HA. pcDNA3-HA-MEK2
was constructed by subcloning a BamHI fragment containing the entire open
reading frame of human MEK2 (41) into the BamHI site of pcDNA3-HA.
Expression vectors for Elk-1 have been described elsewhere (28).
Glutathione S-transferase (GST)–MEK1, GST-ERK1, and a kinase-dead mu-
tant, GST-ERK1 KR, were expressed in Escherichia coli and purified as de-
scribed previously (28, 41). GST-CeMEK2 was expressed and purified as de-
scribed elsewhere (36b).
Metabolic labeling, immunoprecipitation, gel filtration chromatography, and
subcellular fractionation. Subconfluent 293T cells in 10-cm-diameter dishes
were transfected with 10 mg of the indicated expression vector; 48 h posttrans-
fection, cells were labeled for 4 h in cysteine- and methionine-free DMEM–10%
dialyzed FBS (Life Technologies) containing [35S]methionine/cysteine at 200
mCi/ml (Tran35S-label; ICN). Cells were lysed in buffer (10 mM Tris-Cl [pH 7.5],
150 mM NaCl, 50 mM NaF, 1 mM EDTA, 1% Nonidet P-40 [NP-40]) containing
1 mM dithiothreitol [DTT], 1 mM NaVO4, and a protease inhibitor cocktail
(Complete; Boehringer Mannheim) for 20 min at 4°C. Precleared lysates were
incubated for 3 h at 4°C with 10 mg of antibody precoupled to protein G-
Sepharose (Pharmacia) or protein A-agarose (Pierce). For peptide competition,
antibody was preincubated with hemagglutinin (HA) peptide (YPYDVPDYA)
before addition to lysates. Immunocomplexes were collected by gentle centrifu-
gation, washed five times in lysis buffer, boiled in sodium dodecyl sulfate (SDS)
sample, and separated by SDS-polyacrylamide gel electrophoresis (PAGE). For
KSR immunoprecipitation experiments using PC12 cells, 1 mg of extract from
PC12 cells treated with or without NGF for 5 days was immunoprecipitated with
10 mg of KSR-specific antibody (a-KSR; Santa Cruz Biotechnology) in 1%
NP-40–150 mM NaCl lysis buffer. Where indicated, antibody was incubated with
a twofold excess of immunizing peptide prior to immunoprecipitation.
To determine the effects of geldanamycin on KSR protein levels, 293T cells
transfected with HA-KSR were labeled for 30 min with 100 mCi of [35S]methi-
onine/cysteine per ml with or without 10 mM geldanamycin (Sigma), followed by
a chase with complete medium for the indicated times with methionine/cysteine-
containing medium. Lysates were prepared and immunoprecipitated as de-
scribed above with a-HA followed by SDS-PAGE and autoradiography.
For GST pull-down experiments, full-length CeKSR and mKSR cDNAs were
translated in vitro (Promega) in the presence of [35S]methionine. A portion of
the translation reaction mixture was incubated with 5 mg of either GST, GST-
human MEK1, or GST-CeMEK2 bound to glutathione-Sepharose (Pharmacia)
for 1 h at 4°C in 1% NP-40–150 mM NaCl buffer followed by four washes,
SDS-PAGE, and autoradiography.
For gel filtration experiments, two 10-cm-diameter dishes of 293T cells, trans-
fected as described above, were lysed by homogenization in phosphate-buffered
saline (PBS) plus protease and phosphatase inhibitors. Cellular debris was pel-
leted by centrifugation in a microcentrifuge at 6,000 3 g for 15 min at 4°C. The
resulting supernatant (about 1 mg of protein) was fractionated on a Superose
6-HR column (Pharmacia) equilibrated in PBS at a flow rate of 0.5 ml/min.
Fractions of 333 ml, 15 ml of which was subjected to SDS-PAGE and immunoblot
analysis with the indicated antibodies, were collected.
For subcellular fractionation, transfected 293T cells were lysed by homogeni-
zation in PBS containing protease and phosphatase inhibitors. Cellular debris
was removed by centrifugation at 6,000 3 g for 15 min at 4°C. The resulting
supernatant was centrifuged for 1 h at 100,000 3 g at 4°C. The microsomal pellet
(P100) was resuspended in buffer containing 0.5% NP-40 followed by centrifu-
gation at 13,000 3 g to fully remove remaining insoluble material. Equal volumes
of each fraction were examined by SDS-PAGE and immunoblotting with the
indicated antibodies.
Peptide sequencing. a-HA immunocomplexes from approximately 5 3 108
293T cells transfected with HA-KSR were subjected to SDS-PAGE and Coo-
massie blue staining. Bands were excised, digested with lysyl endopeptidase,
purified via reversed-phase high-performance liquid chromatography (HPLC),
and sequenced as described previously (38).
Kinase assays. KSR or MEK immunoprecipitates were equilibrated in buffer
(25 mM HEPES [pH 8.0], 0.5 mM EDTA, 0.25% b-mercaptoethanol) before
addition of 1 mg of GST-ERK1 or GST-ERK1 KR in 10 mM HEPES (pH
8.0)–10 mM MgCl2–1 mM DTT–50 mM ATP in a volume of 30 ml. GST-ERK1
or GST-ERK1 KR activation was allowed to proceed for 15 min at 30°C, after
which 5-ml aliquots were removed and assayed for ERK activity for 15 min at
30°C in 10 mM HEPES (pH 8.0)–10 mM MgCl2–1 mM DTT–50 mM ATP–10
mCi of [g-32PO4]ATP (ICN) and 10 mg of myelin basic protein (MBP; Sigma).
Reactions were terminated by adding EDTA (pH 8.0) to 50 mM, and reaction
mixtures were spotted on P81 phosphocellulose paper (Whatman), washed, and
counted in a scintillation counter.
Two-hybrid interactions and immunoblotting. Two-hybrid screening using
mKSR as a bait was carried out essentially as described elsewhere (35). a-14-3-3
and a-KSR were from Santa Cruz Biotechnology; a-HA was from Babco;
a-phospho-MEK antibody was from New England Biolabs; a-MEK and a-ERK
have been described elsewhere (42); and a-HSP90 was from Transduction Lab-
oratories. Blots were developed by using enhanced chemiluminescence (Amer-
sham).
RESULTS
Integrity of the KSR kinase domain is not required for its
biological function in C. elegans vulval induction. Mutations in
the C. elegans ksr-1 gene were isolated as suppressors of the
Multivulva (Muv) phenotype caused by activated Ras (17, 30),
suggesting that in C. elegans, the KSR-1 protein normally plays
a positive role in Ras-mediated signaling. Of the 12 ksr-1 mu-
tations originally described (17, 30), 8 are missense mutations
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affecting the putative kinase domain; this finding suggested
that kinase activity could be important for KSR-1 function. To
test directly the importance of kinase activity, we constructed
ksr-1 transgenes bearing substitutions predicted to eliminate
kinase activity and tested these transgenes for the ability to
complement the suppressor phenotype caused by ksr-1 loss-of-
function mutations. In these assays, complementation is ob-
served as a restoration of the activated Ras Muv phenotype.
We created a mutant in the Mg21-ATP binding motif (K503M)
as well as a mutant lacking the catalytic nucleophile aspartic
acid (D618A). These residues are highly conserved in protein
kinases, and mutations analogous to these in other protein
kinases have been used to create kinase-inactive molecules.
Surprisingly, both of the kinase-dead transgenes, KSR-1 K503M
and KSR-1 D618A, retained complementing activity compara-
ble to that of wild-type KSR-1 (Table 1). However, a KSR-1
R531H transgene (bearing the same substitution caused by the
endogenous ksr-1 allele ku68) lacked complementing activity.
These data argue that KSR-1 does not require kinase activity
to promote Ras signaling and are inconsistent with models in
which KSR acts as a protein kinase. They do, however, raise
the possibility that KSR has other biochemical functions.
KSR is a component of a high-molecular-weight complex in
vivo. The above results, in addition to repeated failed attempts
to detect intrinsic kinase activity in vitro, led us to test whether
any other biochemical function could be attributed to KSR.
We therefore performed immunoprecipitation experiments us-
ing transfected HEK 293T cells expressing HA-tagged mKSR
to identify KSR-associated proteins. When 35S-labeled a-HA
immunocomplexes were subjected to SDS-PAGE and autora-
diography, we observed that several proteins associated specif-
ically with HA-KSR (Fig. 1A, lane 3). Inclusion of HA peptide
prior to immunoprecipitation competed all coprecipitated pro-
teins, demonstrating the specificity of the immunoprecipitation
(Fig. 1A, lane 2). These coimmunoprecipitated bands were not
due to C-terminal proteolytic degradation of HA-KSR, as im-
munoblot analysis with a-HA detected only KSR. In fact, sev-
eral of the KSR-associated bands have been identified as dis-
tinct cellular proteins, as opposed to fragments of KSR (see
below). In addition, certain KSR-associated proteins can be
coprecipitated by N- or C-terminal truncations of KSR, which
themselves migrate faster than some of the KSR-associated
proteins (Fig. 2A). We obtained similar results using COS1
cells or with a Myc-tagged KSR expression vector. These re-
sults demonstrate that KSR specifically associates with numer-
ous cellular proteins.
We reproducibly detect several major HA-KSR-associated
proteins in immunoprecipitation experiments; a number of
these proteins (p90, p70, p68, p60, p50, p46, p44, and p30) are
present in near-stoichiometric amounts with respect to one
another and can be detected by Coomassie blue staining of as
few as 107 transfected cells (Fig. 1C). Size exclusion chroma-
tography demonstrated that transfected KSR has a molecular
mass of about 106 Da (Fig. 3A), suggesting the possibility that
KSR is a constituent of a multiprotein complex in vivo. These
observations are supported by the fact that a significant portion
of KSR-associated proteins remains bound even under high-
salt conditions (1 M NaCl) or in the presence of 0.1% SDS
(data not shown).
MEK1, MEK2, 14-3-3, HSP90, HSP70, HSP68, and p50CDC37
are components of the KSR complex. Previous reports have
indicated that KSR is capable of associating with MEK1 and -2
as well as 14-3-3 proteins (6, 37, 39). We have also isolated
14-3-3 b and MEK2 in yeast two-hybrid screens using as baits
full-length mKSR and the kinase domain of KSR, respectively
(data not shown). We therefore tested whether MEK1, MEK2,
or 14-3-3 proteins were present in our KSR immunoprecipi-
tates. Immunoblot analysis using a-MEK1/2 clearly detected
the presence of a tightly spaced pair of immunoreactive bands
corresponding to MEK1 and MEK2, respectively (Fig. 1A,
lane 4). The presence of MEK in the KSR complex was also
demonstrated by direct peptide sequencing (Table 2). The
specificity of the KSR-MEK interaction was confirmed by re-
ciprocal coimmunoprecipitation. a-MEK specifically precipi-
tated HA-KSR, which was not precipitated by a nonspecific
antibody (Fig. 1D, lanes 3 to 6).
Similarly, we also probed HA-KSR immunoprecipitates with
a-14-3-3. We detected immunoreactive bands that correspond
well with the predicted molecular mass of 14-3-3 proteins,
approximately 30 kDa (Fig. 1A, lane 4). Immunoprecipitation
with a-14-3-3 also demonstrated the associated HA-KSR (Fig.
1D, lane 2). By peptide sequence analysis, we demonstrated
that the 30-kDa KSR-associated protein is a 14-3-3 protein
(Table 2).
In marked contrast to HA-KSR-transfected cells, no specific
proteins were associated with HA-MEK2 in immunocom-
plexes in the absence of KSR transfection under identical con-
ditions (Fig. 1B, lane 1). Likewise, Myc-14-3-3 b immunocom-
plexes consisted primarily of 14-3-3 (Fig. 1B, lane 2). The fact
that no endogenous KSR was visible in HA-MEK2 and Myc-
14-3-3 b immunocomplexes is consistent with our observation
that 293T cells express little or no endogenous KSR (Fig. 2F).
TABLE 1. The putative kinase activity of KSR is not required for its ability to function in C. elegans vulval inductiona
Chromosomal genotype KSR-1 protein encodedby transgene
% Muv (n) No. of independent
transgenic lines ComplementationF1 F2
let-60(n1046gf); ksr-1(ku68) None 9 (107) 7 (153) 5 2
let-60(n1046gf); ksr-1(ku68) WT 39 (72) 89 (182) 8 1
let-60(n1046gf); ksr-1(ku68) K503M 52 (65) 70 (276) 9 1
let-60(n1046gf); ksr-1(ku68) D618A 54 (93) 59 (160) 7 1
let-60(n1046gf); ksr-1(ku68) R531H 1 (150) 0 (57)b 3 2
let-60(n1046gf); ksr-1(n2526) None 12 (73) 17 (167)b 3 2
let-60(n1046gf); ksr-1(n2526) WT 70 (130) 87 (250) 8 1
let-60(n1046gf); ksr-1(n2526) D618A 66 (79) 66 (181) 8 1
let-60(n1046gf); ksr-1(n2526) K503M 67 (43) 63 (269) 8 1
a Each ksr-1 transgene (5 to 10 ng/ml) was coinjected with the marker plasmid pRF4 (65 to 100 ng/ml), which causes a dominant Roller phenotype (21). F1 and F2
Roller progeny were scored for the Muv phenotype by using a dissecting microscope as described previously (9). F2 data from multiple independent transgenic lines
were pooled. Mutations used were let-60(n1046) (G13E) (1, 9), ksr-1(ku68) (R531H) (29), and ksr-1(n2526) (W255STOP) (17). The ksr-1 transgenes (encoding either
wild-type [WT], K503M, D618A, or R531H KSR-1) consist of genomic positions 1809 (BamHI) to 15401 (BamHI) from cosmid F13B9 (GenBank accession no.
U39853), followed by cDNA positions 520 (BamHI) to 2394 (ClaI) from ksr-1 (GenBank accession no. U38820), followed by genomic positions 19965 (ClaI) to 21454
(SacII) from cosmid F13B9, in pBluescript SK(1).
b Includes F2 and F3 animals.
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Thus, we conclude that the large number of proteins copuri-
fying with HA-KSR are not MEK- and/or 14-3-3-associated
proteins but rather appear to be highly specific and dependent
on the presence of HA-KSR.
To determine the identity of KSR-associated proteins, we
attempted direct protein sequencing from a-HA immunopre-
cipitates. We were successful in obtaining amino acid se-
quences from peptides corresponding to p90, p70, p68, p44/43,
and p30. The sequences of two peptides from p90 were perfect
matches to the human heat shock protein HSP90 (Table 2).
Peptide sequences of p70 and p68 were identical to those of
human HSP70 and HSP68, respectively (Table 2). We also
tested whether p50CDC37 (4, 7, 16, 27), a protein kinase-
targeting subunit of the HSP90 complex, was present in KSR
immunocomplexes. Immunoblot analysis revealed the pres-
ence of a 50-kDa protein using a-p50CDC37, suggesting that
p50CDC37 is capable of associating with KSR (Fig. 1A).
The functions of HSP90 and p50CDC37 have been implicated
in signal transduction and cell cycle regulation through assem-
bly of protein kinase complexes (4, 7, 16, 23, 24, 26, 27, 34).
Therefore, we tested the effects of the HSP90 inhibitor
geldanamycin on KSR protein levels since it has been observed
that geldanamycin treatment reduces levels of Raf, which also
associates with the HSP90 complex (26). Treatment of HA-
KSR-transfected cells with geldanamycin significantly reduced
steady-state levels of KSR yet had no effect on either MEK or
ERK (Fig. 1E). Consistent with this finding brief treatment
of HA-KSR-transfected 293T cells with geldanamycin near-
ly abolished the association between KSR and HSP90 and
p50CDC37, as determined by coimmunoprecipitation experi-
ments (Fig. 1F). To test whether geldanamycin destabilizes
KSR, we performed pulse-chase labeling experiments in the
presence or absence of geldanamycin. Treatment of HA-KSR-
transfected cells with geldanamycin significantly reduced
(.50%) the half-life of HA-KSR (Fig. 1G), suggesting that the
HSP90 complex may act to stabilize KSR in vivo.
Loss-of-function alleles of KSR are defective in MEK1/2
binding. Several missense mutations in CeKSR-1 were identi-
fied as loss-of-function alleles in genetic screens (17, 30). Some
of these are mutations at positions absolutely conserved in all
protein kinases and would therefore be likely to affect the
overall kinase structure of KSR (10). Other mutations, how-
ever, are found in residues conserved only within the Raf and
KSR subfamily of protein kinases. Since our data indicated
that kinase activity was not required for KSR function in C.
elegans, we tested whether mutants analogous to genetically
derived loss-of-function alleles would alter formation of the
multimolecular KSR complex. We constructed HA-KSR ex-
pression vectors bearing the substitution G580E, R615H, or
C809Y in the kinase domain of mKSR corresponding to C.
elegans mutant alleles ku83, ku68, and ku148, respectively (30).
35S metabolic labeling and immunoprecipitation experiments
were performed as described above. These mutant proteins
were efficiently expressed and generally associated with all
KSR-associated proteins exception MEK1 and MEK2 (Fig.
2A). No detectable MEK1 or MEK2 was observed in HA-KSR
C809Y immunoprecipitates, while the amount of MEK1/2 as-
sociated with HA-KSR G580E and R615H mutants was sig-
nificantly reduced (Fig. 2A and B). Thus, in these cases, loss of
ksr-1 function in C. elegans correlates with reduced MEK bind-
ing of the corresponding murine KSR mutant protein. We also
tested HA-KSR-L56G,R57S, containing a substitution in the
CA1 domain corresponding to the Drosophila weak loss-of-
function allele S-548 (31). HA-KSR L56G,R57S displayed
wild-type binding to all KSR-associated proteins.
All protein kinases contain a conserved lysine residue in the
ATP binding domain (10). Surprisingly, both mouse and hu-
man KSRs contain an arginine residue in place of the con-
served lysine at this position, whereas C. elegans and Drosoph-
ila KSRs contain a lysine. HA-KSR R589M, which contains a
methionine in place of this arginine and is presumably kinase
dead, was also tested for its ability to associate with MEK
proteins. HA-KSR R589M also displayed a decreased associ-
ation with MEK1 and MEK2 (roughly 50% of wild-type level)
but still interacted with other KSR-associated proteins (Fig. 2A
and B, lanes 3). This appears to contradict our observation that
a ksr-1 transgene encoding a K503M substitution can still func-
tion in vulva induction. However, it is not clear whether the
two mutant proteins in question, mKSR R589M and CeKSR-1
K503M, are biochemically equivalent.
These observations were expanded upon by immunoblotting
the same immunoprecipitates with a-MEK1/2 and a-14-3-3.
Our results demonstrate that the KSR C809Y mutant is com-
pletely defective in MEK1/2 association yet retains wild-type
affinity for 14-3-3 proteins (Fig. 2B). Similarly, HA-KSR
G580E, R615H, and R589M showed a significant decrease in
MEK1/2 association, while the association with 14-3-3 proteins
was not changed (Fig. 2B).
We tested which regions of KSR mediate binding and com-
plex formation. To accomplish this, we expressed either the
N-terminal amino acids 1 to 301 of KSR (HA-KSR 1-301), a
region which contains the N-terminal CA1 and CA2 domains
(31), or the kinase domain (HA-KSR KD; amino acid 500 to
the stop codon) of KSR. In vivo labeling and immunoprecipi-
tation experiments demonstrated that the isolated kinase do-
main of KSR was sufficient for binding to most of the proteins
detected in full-length HA-KSR immunoprecipitates (Fig. 2A,
lane 9). Specifically, HSP70, HSP68, p60, and p50CDC37 were
capable of associating with the isolated kinase domain of KSR.
Immunoblot analysis with aHSP90 revealed that HSP90 is also
FIG. 1. KSR specifically associates with a number of proteins in vivo. (A) Metabolic labeling and immunoprecipitation (IP) of transfected mouse KSR. 293T cells
were transfected with HA-KSR (lanes 2 and 3) or vector (lane 1), labeled with [35S]Met/Cys, and immunoprecipitated with a-HA (lanes 1 and 3) or with a-HA that
had been preincubated with competitor peptide (lane 2). Immunocomplexes were separated by SDS-PAGE and visualized by autoradiography. Lane 4 represents an
immunoblot of lane 3 probed with a-HA, a-p50CDC37, a-MEK, and a-14-3-3 as indicated. Positions of size markers are indicated in kilodaltons on the left. (B)
Metabolic labeling and immunoprecipitation of transfected MEK and 14-3-3. 293T cells, transfected with HA-MEK2 or Myc-14-3-3 b, were processed as for panel A,
separated by SDS-PAGE, and visualized by autoradiography. (C) Coomassie blue staining of HA-KSR complex affinity purified from 293T cells as for panel A. (D)
HA-KSR is present in MEK1/2 and 14-3-3 immunoprecipitates. 293T cells transfected with HA-KSR were subjected to IP with a-14-3-3 (lanes 1 and 2), a-MEK1/2
(lanes 3 and 4), or control antibody (lanes 5 and 6) as described above, followed by Western blotting (WB) with a-HA to detect HA-KSR. (E) Reduction of KSR protein
levels in response to geldanamycin treatment. HEK 293T cells transfected with HA-KSR were treated with 10 mM geldanamycin for the indicated times before
harvesting and immunoblotting of whole-cell lysates with a-HA (top), a-MEK (middle), and a-ERK (bottom). (F) Geldanamycin treatment selectively disrupts the
association of KSR with HSP90 and p50CDC37. HEK 293T cells transfected with HA-KSR were treated with 10 mM geldanamycin for 1 h (lane 3) before harvesting
and immunoprecipitation with a-HA followed by immunoblotting with a-HA (top), a-HSP90 (middle), and a-p50CDC37 (bottom). HA peptide was included (lane 1)
to demonstrate the specificity of the IP. (G) Geldanamycin destabilizes KSR. HA-KSR-transfected 293T cells were labeled for 30 min with [35S]Met/Cys with or without
geldanamycin. Cells were chased for the indicated times and then immunoprecipitated with a-HA. Cells that had been treated with geldanamycin (lanes 6 to 10) showed
a rapid loss of 35S-labeled HA-KSR. All results in this and subsequent figures are representative examples of at least three independent experiments except for Fig.
3A (performed twice).
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FIG. 2. Mutant KSRs, corresponding to loss-of-function alleles in C. elegans, are compromised in MEK1/2 binding. (A) Metabolic labeling and immunoprecipitation
(IP) of mutant KSRs. 293T cells were transfected with vector (lane 1), wild-type KSR (lane 2), or mutant HA-tagged KSR (lanes 3 to 9). Metabolically labeled lysates
were subjected to IP with a-HA as for Fig. 1A prior to SDS-PAGE and autoradiography. Positions of size markers are indicated in kilodaltons on the right. (B)
Loss-of-function mutant KSR C809Y binds 14-3-3 but not MEK1/2. 293T cells were transfected as for panel A and then immunoprecipitated with a-HA. Immuno-
complexes were separated by SDS-PAGE and immunoblotted with a-HA (to detect HA-KSR; top) a-MEK1/2 (middle), and a-14-3-3 (bottom). KSR C809Y showed
no detectable MEK binding, while KSR R589M, G580E, and R615H displayed reduced MEK binding. (C) KSR forms a signaling complex in vivo with ERK
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easily detectable in HA-KSR KD immunocomplexes, though it
does not appear particularly dramatic on this gel (data not
shown). In contrast, the only proteins that were able to asso-
ciate with the amino-terminal 301 amino acids were p36, p33,
and in a reduced amount, p34 (Fig. 2A, lane 8). These results
suggest that different domains of KSR can bind different KSR-
associated proteins in vivo.
We performed experiments in the yeast two-hybrid system to
determine if KSR directly interacts with MEK. We observed
that LexA-mKSR construct showed little interaction with
MEK1 in the yeast two-hybrid assay (Table 3). In contrast, the
isolated kinase domain of KSR fused to LexA interacts with
MEK1 strongly in yeast. Mutation of cysteine 809 to tyrosine
completely eliminated the interaction with MEK (Table 3).
These results indicate that cysteine 809 of KSR may be directly
involved in its interaction with MEK1 and MEK2. MEK1 and
MEK2 contain a proline-rich region between the kinase sub-
domains IX and X (5, 10, 13). This proline-rich domain has
been implicated in interaction between Raf and MEK and has
a role in the biological function of MEK (5, 13). Our results
indicate that the proline-rich region of MEK1 is not required,
however, for interaction with KSR, as deletion of it had no
effect on KSR KD-MEK1 interaction (Table 3).
KSR mediates protein-protein interactions in vivo. The
presence of ERK was reproducibly detected in the KSR com-
plex (Fig. 2C), consistent with previous observations (39).
However, the amount of ERK associated with KSR appears to
be far less than the amounts of MEK1 and MEK2, since we
cannot detect ERK by Coomassie blue staining, although
MEK1 and MEK2 are easily detectable (Fig. 1D). The associ-
ation between ERK and KSR was confirmed by reciprocal
immunoprecipitation. a-ERK consistently precipitated far less
KSR than a-MEK (Fig. 2D; compare long and short a-HA
exposures). These results indicate that KSR may weakly or
indirectly interact with ERK. Interestingly, the KSR C809Y
mutant failed to precipitate detectable amounts of ERK (Fig.
2C, D), suggesting that MEK1/2 binding may affect this inter-
action.
The results shown in Fig. 2A and B indicate that KSR in-
teracts with MEK and 14-3-3 proteins via different domains.
We tested whether KSR could mediate interactions between
MEK and 14-3-3 proteins. a-14-3-3 precipitated MEK1 and
MEK2 only upon transfection of HA-KSR (Fig. 2E). Further-
more, MEK–14-3-3 interaction was not observed in the ab-
sence of KSR expression or when the MEK binding-defective
KSR C809Y mutant was expressed (Fig. 2E, lane 3). The above
results support the hypothesis that the interaction between
MEK and 14-3-3 is facilitated by KSR and suggest that KSR
can serve as a link between MEK and 14-3-3 proteins.
Induction of KSR in differentiated PC12 cells. We also
tested whether endogenous KSR was associated with MEK,
HSP90, p50CDC37, and 14-3-3. Immunoblot analysis with aKSR
revealed that mouse brain and PC12 cells express detectable
amounts of KSR (Fig. 2F, left panel). a-KSR-reactive bands
were competed by preincubation with peptide antigen, dem-
onstrating the specificity of the antibody (Fig. 2F, right panel).
We also observed that the level of KSR was significantly in-
creased during NGF-induced differentiation of PC12 cells. Im-
munoprecipitation experiments from differentiated PC12 cell
extracts revealed that KSR antibody coprecipitated endoge-
nous MEK1 and MEK2, in addition to HSP90, p50CDC37, and
14-3-3 protein (Fig. 2G). KSR immunoprecipitates from dif-
ferentiated PC12 cells contain considerably more MEK than
those from undifferentiated cells, presumably due to increased
KSR protein levels in differentiated cells (Fig. 2G). We rea-
soned that C. elegans MEK and KSR homologs should be
capable of direct interaction. Therefore, both C. elegans and
murine KSRs were in vitro translated and tested for MEK
binding in a GST pull-down assay using either GST, GST-
CeMEK2 (36b), or GST-human MEK2. Our data clearly indi-
cate that both nematode and mammalian KSRs can specifically
associate with MEKs in vitro (Fig. 2H) and appear to bind with
comparable affinities. These results demonstrate that MEK-
KSR binding is an evolutionarily conserved function of KSR.
KSR recruits MEK to a high-molecular-weight complex and
alters its subcellular distribution. If KSR and MEK form a
large, stable complex, this may be reflected in their molecular
weights and/or subcellular distribution. In 293T cells, MEK1
and MEK2 exhibit an apparent molecular mass of 44 kDa
based on Superose 6 size-exclusion chromatography (Fig. 3A).
This is in good agreement with the predicted molecular
weights of monomeric MEK1 and MEK2. However, in KSR-
transfected cells, the apparent molecular mass of MEK shifts
to approximately 700 kDa (Fig. 3A). In fact, endogenous MEK
quantitatively resides in a high-molecular-weight complex in
KSR-transfected cells. We tested whether this alteration in the
apparent molecular mass of MEK requires its interaction with
KSR. Identical experiments performed with the KSR C809Y
mutant did not alter the apparent molecular mass of MEK
(Fig. 3A). We also tested the possibility that the large KSR
complex that we observed was due to KSR self-oligomeriza-
tion. HA-KSR and a Myc-tagged variant of mKSR were coex-
pressed in 293T cells. Lysates were immunoprecipitated with
either a-HA or a-Myc, and the extent of KSR self-oligomer-
ization was examined by immunoblotting with a-Myc or a-HA.
No detectable KSR oligomerization was observed with either
HA- or Myc-tagged KSR (data not shown). These results sup-
port our hypothesis that the KSR complex contains KSR and
other KSR-associated proteins, including MEK.
MEK normally exists as a soluble cytoplasmic protein (42).
KSR has been reported to exist in both cytoplasmic and mem-
brane-associated forms (22, 37). To test whether association
and MEK. 293T cells were transfected with vector (lane 1), wild-type KSR (lane 2), or HA-KSR C809Y (lane 3) and then immunoprecipitated with a-HA prior to
SDS-PAGE and immunoblotting with a-HA, a-MEK, a-ERK, and a-14-3-3 as indicated. Note that we reproducibly detect far more MEK1/2 (.10-fold) than ERK1/2
associated with HA-KSR in these cells. (D) Comparison of MEK-KSR and ERK-KSR association in vivo. 293T cells, transfected as for panel A, were lysed,
immunoprecipitated with a-MEK (lanes 1 to 3) or a-ERK (lanes 4 to 6), and then immunoblotted with a-HA (to detect KSR; upper two panels), a-ERK (lower panel,
lanes 4 to 6), and a-MEK (lower panel, lanes 1 to 3). Two exposures of the a-HA blot are presented to emphasize the relative amounts of KSR in MEK and ERK
immunoprecipitates. (E) MEK-14-3-3 association is mediated by KSR and dependent on cysteine 809. Lysates were immunoprecipitated with a-14-3-3 and then
immunoblotted with a-MEK (upper panel, lanes 1 to 3) and a-14-3-3 (lower panel). Representative immunoblot of whole-cell extracts shows expression of transfected
HA-KSRs and endogenous MEK, ERK, and 14-3-3 (lanes 4 to 6). IgG, immunoglobulin G. (F) Detection of endogenous KSR in brain and PC12 cells. Extracts from
vector- or HA-KSR-transfected 293T cells or mouse brain were probed with affinity-purified a-KSR. Reactive bands were effectively competed by competition by
peptide antigen. (G) Association of endogenous KSR with MEK, HSP90, p50CDC37, and 14-3-3 in PC12 cells. Lysates from undifferentiated or day 5 differentiated PC12
cells were blotted with a-KSR or a-MEK as indicated. KSR is induced by NGF treatment. Lysates from differentiated PC12 cells were immunoprecipitated with a-KSR
and then immunoblotted with a-MEK, a-HSP90, a-p50CDC37, and a-14-3-3. Where indicated, immunizing peptide was included in the IP. (H) MEK binding is a
conserved function of KSR. 35S-labeled in vitro-translated CeKSR-1a and CeKSR-1b (see Materials and Methods) were incubated with either GST- or GST-CeMEK2
coupled to glutathione-Sepharose. After mixing for 1 h, beads were collected by centrifugation and washed several times in buffer before elution with glutathione. Eluted
proteins were separated by SDS-PAGE and subjected to autoradiography. Mammalian KSR and GST-MEK were included for comparison. Note that CeMEK2 and CeKSR-1
can associate as effectively as their mammalian counterparts.
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with KSR altered the subcellular distribution of MEK, KSR-
transfected cells were fractionated into soluble and particulate
fractions by ultracentrifugation. Immunoblot analysis indicated
that KSR exists in both soluble (S100) and particulate (P100)
fractions (Fig. 3B). Immunoblotting with a-MEK indicated
that a significant portion of MEK existed in the P100 fraction
in KSR-transfected cells (Fig. 3B). Membrane association of
MEK required KSR binding, as the KSR C809Y mutant did
not noticeably alter the subcellular distribution of MEK. As
with KSR C809Y, KSR KD had no detectable effect on MEK
localization. The above observation suggests that a potential
physiological role of KSR is to alter the subcellular distribution
of MEK. It is interesting that the KSR C809Y mutant exists
almost exclusively in the P100 fraction whereas a significant
portion of wild-type KSR remains in the S100 fraction (Fig.
3B). This observation suggests that MEK binding can, in turn,
affect the subcellular distribution of KSR. Thus, it appears that
the localization of MEK and KSR is a cooperative process.
Immunoblotting with a-c-Raf revealed that c-Raf distribution
between S100 and P100 fractions was not significantly altered
by expression KSR (Fig. 3B), which is consistent with our
observation that little endogenous c-Raf is associated with
KSR (data not shown).
KSR-associated MEK is phosphorylated and active. We
tested the effects of expressing wild-type KSR or KSR C809Y
on the ability of MEK1 and MEK2 to undergo phosphorylation
and activation in response to growth factors. Epidermal growth
factor (EGF) stimulated a dramatic increase of active, phos-
phorylated MEK1 and MEK2, which can be detected by
a-phospho-MEK. Cotransfection of either HA-KSR or KSR
C809Y had no effect on the ability of EGF to stimulate MEK1
and MEK2 phosphorylation (Fig. 4A).
To directly examine the phosphorylation state of MEK1 and
MEK2 in the KSR complex, we transfected cells with either
HA-KSR, HA-KSR C809Y, or HA-MEK2; then lysates from
cells grown in the presence of serum were precipitated with
a-HA and blotted with a-MEK and a-phospho-MEK (Fig.
4B). Our results clearly indicate that the MEK1/2 in the KSR
complex is phosphorylated. In fact, the relative phosphoryla-
tion of MEK1/2 in the KSR complex is no less than that in
FIG. 3. KSR exists in a high-molecular-weight complex in vivo. (A) HA-KSR recruits MEK to a large complex. HA-KSR-, HA-KSR C809Y-, or vector-transfected
293T cells were homogenized, and the resulting lysates were fractionated on a Superose 6 column (Pharmacia). Equal volumes of each fraction were subjected to
SDS-PAGE followed by immunoblotting with a-HA (left) and a-MEK (right). Elution profiles of molecular weight standards are indicated (thyroglobulin, 670 kDa;
gamma globulin, 156 kDa; ovalbumin, 44 kDa; myoglobin, 17 kDa; and cobalamin, 1.35 kDa; Bio-Rad Laboratories). Endogenous MEK1/2 exhibits an apparent
molecular mass of 700 kDa only in the presence of HA-KSR (top). In contrast, endogenous MEK elutes at approximately 44 kDa in cells transfected with vector or
KSR C809Y (bottom and middle). (B) KSR alters the cellular distribution of MEK. HA-KSR-, HA-KSR C809Y-, or HA-KSR KD-transfected 293T cells were Dounce
homogenized and then centrifuged at 6,000 3 g for 15 min. The resulting supernatant was spun at 100,000 3 g for 60 min to separate it into soluble (S) and membrane
(P) fractions. Equal volumes of each fraction were subjected to SDS-PAGE and immunoblot analysis with a-HA, a-MEK, and a-c-Raf.
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HA-MEK2 immunoprecipitates without KSR transfection
(Fig. 4B). We also directly examined the ability of growth
factors to induce MEK activity in the KSR complex by a cou-
pled kinase assay. Our results indicate that coprecipitated
MEK1/2 in the KSR complex is fully capable of activating
recombinant ERK1 (Fig. 4C and D). Furthermore, the specific
activity of MEK in the KSR complex was no different than that
of HA-MEK2 alone (Fig. 4C and D). HA-KSR C809Y immu-
nocomplexes contained virtually no detectable MEK activity.
This finding is consistent with our observation that the C809Y
mutant is unable to associate with MEK and also demonstrates
the high specificity of this kinase assay (Fig. 4D). These results
demonstrate that KSR-bound MEK1/2 can be phosphorylated
and activated by Raf, and, in turn, can phosphorylate and ac-
tivate GST-ERK1 in vitro. Our results support the hypothesis
that KSR inhibits neither the activity nor the activation of MEK
but rather modulates its localization in the cell. However, it
remains possible that the effect of KSR on MEK activation is
cell type dependent or dependent on relative expression levels.
KSR C809Y is defective Elk-1 regulation. We have observed
that KSR can specifically block phosphorylation and activation
of Elk-1, a physiological substrate of MAP kinases (29). To test
the relationship between the ability of KSR to block Elk-1
phosphorylation and its ability to interact with MEK, KSR
C809Y was used. Although C809Y may affect other functions
of KSR, a plausible explanation is that KSR-MEK interaction
is needed for its ability to block Elk-1 activation in these cells.
We tested this hypothesis. KSR effectively blocked EGF-stim-
ulated Elk-1 phosphorylation, while KSR C809Y had no effect
on Elk-1 phosphorylation (Fig. 5A). This result suggests that
the ability of KSR to bind MEK1 and MEK2 may correlate
with its ability to block Elk-1 activation by MAP kinases. We
also tested truncated mutants of KSR in the same assay to
determine which regions of KSR are necessary and sufficient to
inhibit Elk-1. Our results show that the full-length KSR protein
is required to inhibit Elk-1 activation (Fig. 5B).
DISCUSSION
Kinase-independent function of KSR. KSR was originally
identified by genetic means to be a regulator of Ras-MAP
kinase signaling pathways controlling Drosophila photorecep-
tor differentiation and C. elegans vulval induction (17, 30, 31).
Subsequent studies confirmed that KSR indeed plays a role in
Ras-MAP kinase signaling in Xenopus and mammalian cells as
well (6, 14, 29, 32, 37, 39). However, the mechanism of KSR
function is not well understood in any system. Although the
sequence of KSR predicts it to be a protein kinase, to date we
are unable to demonstrate any kinase activity intrinsic to KSR
whether it is expressed in bacteria, insect cells, or mammalian
cells as either a full-length protein or the isolated C-terminal
kinase domain. Our C. elegans data argue that if KSR is a
protein kinase, this activity is not required for its positive
signaling function during vulval induction.
We observed that mutation of the Mg21-ATP-coordinating
lysine residue (KSR-1 K503M) or the catalytic nucleophile
aspartic acid residue (KSR-1 D618A) did not compromise the
function of ksr-1 in C. elegans vulval induction, although these
mutations are frequently used to render a protein kinase dead.
Since these complementation assays rely on transgenes, which
are likely overexpressed, it remains possible that endogenous
levels of a KSR-1 (kinase-dead) protein are signaling deficient.
Nevertheless, our data clearly indicate that a kinase-indepen-
dent function of KSR-1 can promote vulval induction. Our
data are consistent with previous reports that a kinase-inde-
pendent function of KSR can enhance Ras-induced germinal
vesicle breakdown in Xenopus oocytes (22, 31) but are incon-
sistent with a report that KSR acts as a ceramide-activated
protein kinase (40). One likely kinase-independent function of
KSR is suggested by our finding that murine KSR forms a
multimolecular complex in vivo.
Components of the KSR complex. The KSR complex dis-
plays an apparent molecular mass of roughly 106 Da, as deter-
mined by size-exclusion chromatography. Immuneprecipita-
tion of HA-KSR revealed numerous cellular proteins that
specifically coprecipitate with KSR. We consistently observed
the following proteins in the KSR complex affinity purified
from HEK 293T cells: HSP90, HSP70, HSP68, p50CDC37,
p60, MEK1, MEK2, p36, p34, p33, and 14-3-3. Data derived
from experiments using deletion and point mutants of KSR
suggest that different regions of KSR may mediate interactions
with distinct signaling proteins. For example, the N-terminal
domain of KSR (amino acids 1 to 301) interacts with p36, p34,
and p33. Similarly, the C-terminal kinase domain of KSR in-
teracts with a unique and distinct set of proteins, notably,
HSP90, HSP70, HSP68, and p50CDC37. It is not clear whether
all KSR-associated proteins directly interact with KSR, nor do
we know that each of the associated proteins exists in the same
complex in vivo. However, our data strongly suggest that MEK
directly binds KSR, as this interaction is observed in yeast and
in vitro binding assays. Furthermore, KSR C809Y, which cor-
responds to a loss-of-function allele in C. elegans, cannot inter-
act with MEK yet can still associate with other KSR-associated
TABLE 2. Peptide sequence analysis of KSR-associated proteinsa












a a-HA immunoprecipitates from 5 3 108 transfected cells were subjected to
SDS-PAGE followed by silver staining. Bands corresponding to KSR-associated
proteins were excised, digested with lysyl endopeptidase, and purified via reversed-
phase HPLC (38), and the amino acid sequence was determined via Edman
degradation. Peptide sequence identities were determined by using the Blast-P
database search program (National Center for Biotechnology Information).
TABLE 3. KSR interacts with 14-3-3 and MEK1 in
the yeast two-hybrid system
Bait
Interaction with indicated targeta
Vector 14-3-3 MEK1 MEK1DP
Lamin 2 2 2 2
KSR 2 1 2 2
KSR KD 2 2 1 1
KSR KD C809Y 2 2 2 2
a A positive interaction denotes both a positive signal by His31 and positive
staining of b-galactosidase. KSR KD is the C-terminal kinase domain of the
KSR. KSR KD C809Y contains a point mutation of Cys809 replaced by Tyr; this
mutant corresponds to a loss-of-function KSR allele, ku148, isolated from
C. elegans (30). MEK1DP is a MEK1 construct lacking the proline-rich domain
between kinase subdomains X and XI (10).
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molecules. Similarly, KSR is likely to directly interact with
14-3-3. 14-3-3 proteins have been shown to interact with nu-
merous cellular proteins, including Raf, KSR’s closest relative.
Previous reports have demonstrated interactions between
KSR and other proteins, including Raf, MEK, ERK, and 14-
3-3 (6, 14, 22, 37, 39). These studies were based on yeast two-
hybrid and/or coimmunoprecipitation experiments and have
revealed little information regarding the relative strength or
functional significance of these interactions. Similarly, it has
not been demonstrated whether KSR is capable of simulta-
neous interactions with different signaling molecules. In this
report, we have identified several novel KSR-associated pro-
teins (HSP90, HSP70, HSP68, p50CDC37, p36, p34, and p32) in
addition to those previously reported. Furthermore, we dem-
onstrated that KSR is capable of forming a multimolecular
complex, although binding affinities among known KSR-asso-
ciated proteins appear to vary considerably. Specifically, the
three kinases of the MAP kinase cascade, Raf, MEK, and
ERK, display markedly different abilities to associate with
KSR in HEK 293T cells. We consistently observe that MEK
stoichiometrically associates with KSR, where as a small frac-
tion of ERK it is detected in KSR immunocomplexes. The
FIG. 4. KSR-associated MEK is phosphorylated and can activate ERK in response to growth factors. (A) KSR expression does not effect MEK1/2 phosphorylation
at serine 218/222. 293T cells were transfected with vector, HA-KSR, or HA-KSR C809Y (1 mg of each). After 24 h of serum deprivation, cells were stimulated for 5
min with EGF (50 ng/ml) as indicated. Whole-cell extracts were prepared and separated by SDS-PAGE followed by immunoblot analysis with a-phospho-MEK1/2,
a-MEK, and a-HA, as indicated (lower panel). (B) MEK in the KSR complex is phosphorylated. a-HA immunoprecipitates from vector-, HA-KSR-, HA-KSR C809Y-,
or HA-MEK2-transfected 293T cells were subjected to SDS-PAGE and immunoblot analysis with a-phospho-MEK1/2, a-MEK, and a-HA, as indicated. Note that the
electrophoretic mobility of HA-MEK2 is slower than that of endogenous MEK due to the presence of two HA epitopes at its amino terminus. (C) KSR-associated MEK
is active. Equal amounts of MEK from each of the immunoprecipitates shown in panel B were used to activate recombinant GST-ERK1 in a coupled kinase assay using
MBP as a substrate (see Materials and Methods). (D) Binding of KSR to MEK does not alter the ability of MEK to activate ERK in response to growth factor
stimulation. 293T cells were transfected with the indicated KSR or MEK expression vector. After 24 h of serum starvation, cells were stimulated with EGF for 5 min
as indicated and then immunoprecipitated with a-HA. Equal amounts of MEK from all immunoprecipitates were used to activate recombinant GST-ERK1 or
GST-ERK1 KR (kinase-inactive control) in a coupled kinase assay.
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fraction of Raf that associates with KSR appears to be smaller
still. The data presented here significantly advance the concept
of KSR as a scaffolding protein in the Ras-MAP kinase pathway.
Involvement of the HSP90 complex in KSR and Ras sig-
naling. It is noteworthy that HSP90, HSP70, HSP68, and
p50CDC37 are components of the KSR complex. HSP90 has
been observed to interact with numerous proteins, including
steroid hormone receptors and protein kinases (24). Protein-
protein interactions with HSP90 appear to be important for
maintaining both protein stability and biological function. In
addition, p50CDC37 has been proposed to be a protein kinase-
targeting subunit of HSP90 (27). Consistent with this, inhi-
bition of HSP90 with geldanamycin abolishes association
between KSR and p50CDC37. In addition, geldanamycin de-
stabilizes KSR in vivo, suggesting a role for these proteins in
maintaining levels of KSR. HSPs are also known to facilitate
protein folding, and it remains possible that KSR exists in both
folded and unfolded forms in our experimental setting. There-
fore, it may be difficult to determine whether KSR-HSP90
interactions are biologically significant. Our data do support
the hypothesis that KSR-MEK interactions are physiological in
nature, as KSR and MEK appear to associate at endogenous
protein levels in PC12 cells (Fig. 2G and reference 39). It is
noteworthy that KSR protein levels are induced during PC12
cell differentiation. The Ras-MAP kinase pathway plays a piv-
otal role in PC12 cell differentiation, and further experiments
seem warranted to determine whether KSR is involved in this
system. Based on several lines of evidence, our data support
the model in which HSP90-KSR interactions are also physio-
logically relevant. First, almost equal amounts of HSPs, MEK,
and 14-3-3 proteins are found associated with KSR. Second,
distinct regions of KSR mediate protein-protein interactions
with HSPs. Third, low-level expression of KSR yields a similar
set of coprecipitated molecules. Furthermore, we show here
that HSP90 plays a positive role in maintaining KSR protein
levels. Finally, mutations in both HSP90 and p50CDC37 have
been identified by using genetic screens very similar to those
in which KSR was isolated, suggesting that these molecules
may function in the same pathway (4, 34).
A model for KSR function as a scaffolding protein. Scaffold-
ing proteins of other MAP kinase pathways have been shown
to maintain specificity and to enhance signaling efficiency (3,
19, 36a). The best example is the Ste5 protein, which tethers
components of the Fus3 MAP kinase pathway in the mating
pheromone response in budding yeast. Ste5p is essential for
mating and maintains specificity of the Fus3p MAP kinase
cascade (3, 19). Recently, a scaffolding protein of the mamma-
lian stress-activated MAP kinase cascade has been reported
(36a). Although the molecular structure of the KSR complex
requires further biochemical characterization, we favor the
model in which KSR can simultaneously and directly interact
with multiple cellular proteins to form a large signaling com-
plex. Some of the components, such as MEK, HSPs, and 14-
3-3, associate with KSR with high stoichiometry. Other com-
ponents, such as ERK, may transiently (or in a regulated
manner) associate with KSR with low stoichiometry. KSR has
been reported to weakly interact with Raf in a Ras-dependent
manner (22, 32, 37), and we detect Raf-KSR association only
upon overexpression of both proteins (data not shown).
We propose that KSR functions in vivo to recruit numerous
molecules to form a large signaling complex. Consistent with
this model, several loss-of-function mutants exhibited reduced
MEK association in vivo. Furthermore, MEK binding is a
conserved function of both murine and C. elegans KSRs,
though it is not known whether the two are functionally inter-
changeable. A plausible explanation is that KSR’s interaction
FIG. 5. Effects of KSR mutants on Elk-1 phosphorylation. (A) KSR C809Y
is deficient in Elk-1 inhibition. 293T cells were transfected with Elk-1 (250 ng)
and either vector, HA-KSR, or HA-KSR C809Y (1 mg). After 24 h of serum
starvation, cells were stimulated with EGF (50 ng/ml) for 5 min prior to lysis and
immunoblotting with the indicated antibodies. a-Phospho-Elk-1 recognizes only
phosphorylated, active Elk-1. (B) Neither the isolated amino terminus nor the
kinase domain of KSR is sufficient to block Elk-1 phosphorylation. 293T cells
were transfected with Elk-1 and the indicated KSR expression vector. After 24 h
of serum starvation, cells were stimulated with EGF (50 ng/ml) for 5 min prior
to lysis and immunoblotting with a-phospho-Elk-1 (top), a-Elk-1 (middle), and
a-HA (bottom).
VOL. 19, 1999 KSR SIGNALING COMPLEX 5533
with MEK is important for its physiological functions. KSR
appears to be a core component of this complex and may
function as a scaffold protein to maintain specificity and to
increase or restrict the signaling kinase cascade. Other com-
ponents of the MAP kinase cascade may transiently interact
with the complex, depending on intracellular signaling condi-
tions. For example, Raf might transiently interact with the
complex and activate the associated MEK. Similarly, ERK may
temporally associate with the KSR complex, where it can un-
dergo activation by the tightly bound MEK. Finally, our data
suggest that the ability of KSR to form a signaling complex may
be more important than its putative kinase activity for its phys-
iological function. The precise role of the KSR signaling com-
plex should be clarified by the identification of the remaining
KSR-associated proteins and by the identification of loci that
interact genetically with ksr-1 in C. elegans and Drosophila.
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